128940.KS · 한미약품
South Korea · RS rating 39 · As of 2026-10-14
| Price | 404,000.00 KRW |
|---|---|
| 1-day change | -9.2% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 8 / 46 / 72 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 25 / 49 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +83.1% |
| Sales growth Q/Q | +18.9% |
| Distance from 52-week high | +35.5% |
| Market cap (USD) | $4.5B |